Alkem Laboratories board to review quarterly and half-year financial results

Alkem Laboratories Limited has announced a meeting of its board of directors to be held on Thursday, November 13, 2025. The primary agenda for this meeting is to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2025. This notice was issued on October 23, 2025.

The announcement was made to both the BSE Limited and the National Stock Exchange of India Limited. This disclosure adheres to Regulation 29, read with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Manish Narang, president – legal, company secretary & compliance officer, digitally signed the notification. The financial outcomes from this meeting will provide insights into the company’s performance over the specified period.